GEBRO and Spektus sign collaboration for ActraFlex
Both companies will manage regulatory approval processes and commercial operations within their allocated territories.
Drug Development
FDA to review uniQure’s BLA for Huntington’s gene therapy
Inovio’s Voceryq receives FDA accelerated approval for RRP
Dren Bio raises $350m for dibotatug clinical development
Enthorin and Rumi sign agreement for FXS therapy
Formation Bio launches $600m drug development fund
FDA grants orphan drug status to Octant’s OCT-980 for RP
Arrowhead gains UK marketing authorisation for Redemplo
